Profusa (PFSA) Change in Account Payables (2022 - 2026)
Profusa's (PFSA) quarterly Change in Account Payables came in at $964000.0 in Q1 2026, up 26.18% year-on-year from $764000.0 in Q1 2025, and up 165.56% quarter-over-quarter from $363000.0 in Q4 2025.
Profusa (PFSA) Change in Account Payables (2022 - 2026) Analysis & Trends
Profusa's Change in Account Payables history runs 5 years deep, the most recent figure standing at $964000.0 for Q1 2026.
- On a quarterly basis, Change in Account Payables rose 26.18% year-over-year to $964000.0 in Q1 2026; TTM through Mar 2026 was $3.8 million, a 182.67% increase from a year earlier, with the FY2025 full-year figure at $3.6 million, up 451.94% from the prior year.
- Change in Account Payables rose to $964000.0 in Q1 2026 per PFSA's latest filing, from $363000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.1 million in Q3 2025 and bottomed at -$45000.0 in Q4 2024.
- The 5-year median for Change in Account Payables is $46907.5 (2022), against an average of $324563.8.
- Across the five-year window, Change in Account Payables plunged 295.77% in 2023 and soared 1079.35% in 2024, its largest moves.
- Year by year, Change in Account Payables stood at $15000.0 in 2022, then plunged by 295.77% to -$29366.0 in 2023, then tumbled by 53.24% to -$45000.0 in 2024, then surged by 906.67% to $363000.0 in 2025, then surged by 165.56% to $964000.0 in 2026.
- Per Business Quant, the three latest PFSA Change in Account Payables figures stand at $964000.0 (Q1 2026), $363000.0 (Q4 2025), and $2.1 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Profusa | 23,566.40 | -351,433.60 | - | 964,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 964,000.00 |
| Mar 31, 2026 | 964,000.00 |
| Dec 31, 2025 | 363,000.00 |
| Dec 31, 2025 | 363,000.00 |
| Sep 30, 2025 | 2.14 Mn |
| Sep 30, 2025 | 2.14 Mn |
| Jun 30, 2025 | 296,055.00 |
| Jun 30, 2025 | 296,055.00 |
| Mar 31, 2025 | 764,000.00 |
| Mar 31, 2025 | 764,000.00 |
| Dec 31, 2024 | -45,000.00 |
| Dec 31, 2024 | -45,000.00 |
| Sep 30, 2024 | 434,283.00 |
| Sep 30, 2024 | 434,283.00 |
| Jun 30, 2024 | 176,902.00 |
| Jun 30, 2024 | 176,902.00 |
| Mar 31, 2024 | 78,815.00 |
| Mar 31, 2024 | 78,815.00 |
| Dec 31, 2023 | -29,366.00 |
| Dec 31, 2023 | -29,366.00 |